Evidence map›Paper›PMID 35245177›Full record

ArticleeLife2022

In vivo transcriptomic profiling using cell encapsulation identifies effector pathways of systemic aging.

Omid Mashinchian, Xiaotong Hong, Joris Michaud, Eugenia Migliavacca, Gregory Lefebvre, Christophe Boss, Filippo De Franceschi, Emmeran Le Moal, Jasmin Collerette-Tremblay, Joan Isern and 7 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Polymeric Hydrogels for In Vitro 3D Ovarian Cancer Modeling.International journal of molecular sciences · 2022
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 4 countries.

Omid Mashinchian *Nestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.
Xiaotong Hong *Nestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.
Joris Michaud *Nestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.
Eugenia Migliavacca *Nestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.
Gregory LefebvreNestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.
Christophe BossNestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.
Filippo De FranceschiNestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.
Emmeran Le MoalDépartement de Pharmacologie-Physiologie, Institut de Pharmacologie de Sherbrooke, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Canada.
Jasmin Collerette-TremblayDépartement de Pharmacologie-Physiologie, Institut de Pharmacologie de Sherbrooke, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Canada.
Joan IsernVascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.ORCID 0000-0002-1401-9779
Sylviane MetaironNestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.
Frederic RaymondNestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.
Patrick DescombesNestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.
Nicolas BoucheNestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.
Pura Muñoz-CánovesVascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
Jerome N FeigeNestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.ORCID 0000-0002-4751-264X
C Florian BentzingerNestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.ORCID 0000-0003-0422-9622
Nestlé (Brazil) · BRUniversité de Sherbrooke · CAInstitució Catalana de Recerca i Estudis Avançats · ES

Funding

CIHR PJT-162442
6 · The paper itself

Abstract

Sustained exposure to a young systemic environment rejuvenates aged organisms and promotes cellular function. However, due to the intrinsic complexity of tissues it remains challenging to pinpoint niche-independent effects of circulating factors on specific cell populations. Here, we describe a method for the encapsulation of human and mouse skeletal muscle progenitors in diffusible polyethersulfone hollow fiber capsules that can be used to profile systemic aging in vivo independent of heterogeneous short-range tissue interactions. We observed that circulating long-range signaling factors in the old systemic environment lead to an activation of Myc and E2F transcription factors, induce senescence, and suppress myogenic differentiation. Importantly, in vitro profiling using young and old serum in 2D culture does not capture all pathways deregulated in encapsulated cells in aged mice. Thus, in vivo transcriptomic profiling using cell encapsulation allows for the characterization of effector pathways of systemic aging with unparalleled accuracy.

Indexed as

Satellite Cells, Skeletal MuscleStem CellsAgingAnimalsCell DifferentiationCell EncapsulationMiceMuscle, SkeletalTranscriptomeagingcell biologycell encapsulationmouseMuSCsmyogenic progenitorssatellite cellsskeletal muscletranscriptomics

Identifiers

PMID35245177
PMCPMC8926399
OpenAlexW4214867027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.